Durvalumab-induced organizing pneumonia in extensive-stage small cell lung cancer: A case report and literature review

Durvalumab-induced organizing pneumonia in extensive-stage small cell lung cancer: A case report and literature review

The etoposide-carboplatin and anti-PD-L1 combination has become the standard-of-care for patients with extensive-stage small cell lung cancer (ES-SCLC). This combinational strategy is well tolerated with manageable immune-related adverse effects (irAEs). In this report, we presented a rare immediate...

Full description

Saved in:
Bibliographic Details
Main Authors: Guoxin Wang, MD, Wenjie Yan, MD, Jun Cai, MD, Fang Zhang, MD, Tangfeng Lv, MD, Mingxiang Ye, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Radiology Case Reports
Subjects:
Extensive-stage small cell lung cancer
Anti-PD-L1 immunotherapy
Immune-related adverse effects
Organizing pneumonia
Ground glass opacifications
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043325000743
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1930043325000743

Similar Items